Epicardial adipose tissue has a unique transcriptome modified in severe coronary artery disease

Obesity

Volumn 23, Issue 6, 2015, Pages 1267-1278

  McAninch, Elizabeth A ^a   Fonseca, Tatiana L ^a   Poggioli, Raffaella ^b   Panos, Anthony L ^b   Salerno, Tomas A ^b   Deng, Youping ^a   Li, Yan ^a   Bianco, Antonio C ^a   Iacobellis, Gianluca ^b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LECTIN; TRANSCRIPTOME; TRANSFORMING GROWTH FACTOR BETA;

ADIPOSE TISSUE; ADULT; APOPTOSIS; ARTICLE; BLOOD CLOTTING; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE SEVERITY; DOWN REGULATION; ENDOPLASMIC RETICULUM STRESS; ENDOTHELIUM; EPICARDIAL ADIPOSE TISSUE; FEMALE; GENE EXPRESSION REGULATION; HUMAN; INNATE IMMUNITY; MALE; METABOLIC SYNDROME X; MICROARRAY ANALYSIS; OXIDATIVE STRESS; PILOT STUDY; POTASSIUM TRANSPORT; PROTEIN DEGRADATION; PROTEIN METABOLISM; SIGNAL TRANSDUCTION; SUBCUTANEOUS FAT; TRANSCRIPTION REGULATION; TRANSCRIPTOMICS; VALVULAR HEART DISEASE; COMPARATIVE STUDY; GENETICS; METABOLISM; PERICARDIUM;

ADIPOSE TISSUE; CORONARY ARTERY DISEASE; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; PERICARDIUM; PILOT PROJECTS; TRANSCRIPTOME;

EID: 84929950829     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.21059     Document Type: Article

References (37)

1. Iacobellis G, Assael F, Ribaudo MC, et al., Epicardial fat from echocardiography: A new method for visceral adipose tissue prediction. Obes Res 2003; 11: 304-310.
2. Marchington JM, Mattacks CA, Pond CM,. Adipose tissue in the mammalian heart and pericardium: Structure, foetal development and biochemical properties. Comp Biochem Physiol B 1989; 94: 225-232.
3. Iacobellis G, Corradi D, Sharma AM,. Epicardial adipose tissue: Anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med 2005; 2: 536-543.
4. Bambace C, Telesca M, Zoico E, et al., Adiponectin gene expression and adipocyte diameter: A comparison between epicardial and subcutaneous adipose tissue in men. Cardiovasc Pathol 2011; 20: e153-156.
5. Mazurek T, Zhang L, Zalewski A, et al., Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 2003; 108: 2460-2466.
6. Sacks HS, Fain JN,. Human epicardial adipose tissue: A review. Am Heart J 2007; 153: 907-917.
7. Iacobellis G, Bianco AC,. Epicardial adipose tissue: Emerging physiological, pathophysiological and clinical features. Trends Endocrinol Metab 2011; 22: 450-457.
8. Marchington JM, Pond CM,. Site-specific properties of pericardial and epicardial adipose tissue: The effects of insulin and high-fat feeding on lipogenesis and the incorporation of fatty acids in vitro. Int J Obes 1990; 14: 1013-1022.
9. Pezeshkian M, Noori M, Najjarpour-Jabbari H, et al., Fatty acid composition of epicardial and subcutaneous human adipose tissue. Metab Syndr Relat Disord 2009; 7: 125-131.
10. Salgado-Somoza A, Teijeira-Fernandez E, Fernandez AL, Gonzalez-Juanatey JR, Eiras S,. Proteomic analysis of epicardial and subcutaneous adipose tissue reveals differences in proteins involved in oxidative stress. Am J Physiol Heart Circ Physiol 2010; 299: H202-209.
11. Fain JN, Sacks HS, Bahouth SW, Tichansky DS, Madan AK, Cheema PS,. Human epicardial adipokine messenger RNAs: Comparisons of their expression in substernal, subcutaneous, and omental fat. Metabolism 2010; 59: 1379-1386.
12. Baker AR, Silva NF, Quinn DW, et al., Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc Diabetol 2006; 5: 1.
13. Mahabadi AA, Berg MH, Lehmann N, et al., Association of epicardial fat with cardiovascular risk factors and incident myocardial infarction in the general population: The Heinz Nixdorf Recall Study. J Am Coll Cardiol 2013; 61: 1388-1395.
14. Pierdomenico SD, Pierdomenico AM, Cuccurullo F, Iacobellis G,. Meta-analysis of the relation of echocardiographic epicardial adipose tissue thickness and the metabolic syndrome. Am J Cardiol 2013; 111: 73-78.
15. Subramanian A, Tamayo P, Mootha VK, et al., Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 2005; 102: 15545-15550.
16. Dutour A, Achard V, Sell H, et al., Secretory type II phospholipase A2 is produced and secreted by epicardial adipose tissue and overexpressed in patients with coronary artery disease. J Clin Endocrinol Metabol 2010; 95: 963-967.
17. Guauque-Olarte S, Gaudreault N, Piche ME, et al., The transcriptome of human epicardial, mediastinal and subcutaneous adipose tissues in men with coronary artery disease. PloS One 2011; 6: e19908.
18. Iacobellis G, Willens HJ,. Echocardiographic epicardial fat: A review of research and clinical applications. J Am Soc Echocardiogr 2009; 22: 1311-1319; quiz 1417-1318.
19. Huber J, Kiefer FW, Zeyda M, et al., CC chemokine and CC chemokine receptor profiles in visceral and subcutaneous adipose tissue are altered in human obesity. J Clin Endocrinol Metabol 2008; 93: 3215-3221.
20. Cheng KH, Chu CS, Lee KT, et al., Adipocytokines and proinflammatory mediators from abdominal and epicardial adipose tissue in patients with coronary artery disease. Int J Obes (Lond) 2008; 32: 268-274.
21. Yang RZ, Lee MJ, Hu H, et al., Identification of omentin as a novel depot-specific adipokine in human adipose tissue: Possible role in modulating insulin action. Am J Physiol Endocrinol Metab 2006; 290: E1253-1261.
22. Ekstrom M, Liska J, Eriksson P, Sverremark-Ekstrom E, Tornvall P,. Stimulated in vivo synthesis of plasminogen activator inhibitor-1 in human adipose tissue. Thromb Haemost 2012; 108: 485-492.
23. Lijnen HR,. Functional role of the fibrinolytic system in development of adipose tissue. Verh K Acad Geneeskd Belg 2009; 71: 101-113.
24. Svensson PA, Jernas M, Sjoholm K, et al., Gene expression in human brown adipose tissue. Int J Mol Med 2011; 27: 227-232.
25. Decher N, Maier M, Dittrich W, et al., Characterization of TASK-4, a novel member of the pH-sensitive, two-pore domain potassium channel family. FEBS Lett 2001; 492: 84-89.
26. Matarin M, Brown WM, Scholz S, et al., A genome-wide genotyping study in patients with ischaemic stroke: Initial analysis and data release. Lancet Neurol 2007; 6: 414-420.
27. Koo GC, Blake JT, Talento A, et al., Blockade of the voltage-gated potassium channel Kv1.3 inhibits immune responses in vivo. J Immunol 1997; 158: 5120-5128.
28. Tschritter O, Machicao F, Stefan N, et al., A new variant in the human Kv1.3 gene is associated with low insulin sensitivity and impaired glucose tolerance. J Clin Endocrinol Metabol 2006; 91: 654-658.
29. Yang Q, Huang JH, Man YB, Yao XQ, He GW,. Use of intermediate/small conductance calcium-activated potassium-channel activator for endothelial protection. J Thorac Cardiovasc Surg 2011; 141: 501-510, 510 e501.
30. Regan SE, Broad M, Byford AM, et al., A1 adenosine receptor overexpression attenuates ischemia-reperfusion-induced apoptosis and caspase 3 activity. Am J Physiol Heart Circ Physiol 2003; 284: H859-866.
31. Matherne GP, Linden J, Byford AM, Gauthier NS, Headrick JP,. Transgenic A1 adenosine receptor overexpression increases myocardial resistance to ischemia. Proc Natl Acad Sci U S A 1997; 94: 6541-6546.
32. Wing SS,. The UPS in diabetes and obesity. BMC Biochem 2008; 9 (Suppl 1): S6.
33. Aggarwal K, Massague J,. Ubiquitin removal in the TGF-beta pathway. Nat Cell Biol 2012; 14: 656-657.
34. Houstis N, Rosen ED, Lander ES,. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 2006; 440: 944-948.
35. Holvoet P, De Keyzer D, Jacobs DR, Jr,. Oxidized LDL and the metabolic syndrome. Future Lipidol 2008; 3: 637-649.
36. Mazurek T, Kiliszek M, Kobylecka M, et al., Relation of proinflammatory activity of epicardial adipose tissue to the occurrence of atrial fibrillation. Am J Cardiol 2014; 113: 1505-1508.
37. Mazurek T, Kochman J, Kobylecka M, et al., Inflammatory activity of pericoronary adipose tissue may affect plaque composition in patients with acute coronary syndrome without persistent ST-segment elevation: Preliminary results. Kardiol Pol 2014; 72: 410-416.